Karen Ferrante
Direktor/Vorstandsmitglied bei MACROGENICS, INC.
Vermögen: 63 521 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Scott Koenig | M | 71 | 24 Jahre | |
| Jessica Sachs | M | 49 | 12 Jahre | |
| David Mims | M | 60 | 5 Jahre | |
| Peter Harwin | M | 38 | 4 Jahre | |
| Andrew Robbins | M | 48 | 4 Jahre | |
| Douglas Lankler | M | 58 | 25 Jahre | |
| Margaret Liu | M | 67 | 1 Jahre | |
| Matthew Ros | M | 57 | 5 Jahre | |
| Chris Cain | M | 40 | 4 Jahre | |
| Evan Kearns | M | 43 | 3 Jahre | |
| Jay Siegel | M | 71 | 7 Jahre | |
| Jeffrey Peters | M | 53 | 9 Jahre | |
| Todd Shegog | M | 59 | 3 Jahre | |
| Meenu Chhabra Karson | F | 51 | 1 Jahre | |
| James Karrels | M | 57 | 16 Jahre | |
| Eric Risser | M | 51 | 15 Jahre | |
| Paul Carter | M | 63 | 7 Jahre | |
| Scott Jackson | M | 59 | 7 Jahre | |
| David Stump | M | 74 | 11 Jahre | |
| Edward Hurwitz | M | 60 | 20 Jahre | |
| Graeme Jack | M | 73 | 7 Jahre | |
| John Green | M | 43 | 6 Jahre | |
| Arlene Morris | F | 72 | 5 Jahre | |
| William Heiden | M | 64 | 2 Jahre | |
| Federica O’Brien | F | 66 | 3 Jahre | |
| Lynn Cilinski | F | 66 | 21 Jahre | |
| Ezio Bonvini | M | 70 | 21 Jahre | |
| Dana Martin | M | - | 3 Jahre | |
| Michael Shi | M | 59 | 2 Jahre | |
| Annaliesa Anderson | M | - | 17 Jahre | |
| Christopher O'Reilly | M | - | 13 Jahre | |
| Markus Green | M | - | 18 Jahre | |
| Mike McDermott | M | 58 | 21 Jahre | |
| Brad Barnett | M | - | - | |
| Erin Schellhammer | F | - | - | |
| Sara Saltzman | F | - | 5 Jahre | |
| Mwana Lugogo | M | 54 | 12 Jahre | |
| Thomas Spitznagel | M | 57 | 11 Jahre | |
| John Robinson | M | 50 | 3 Jahre | |
| Christi Waarich | F | - | - | |
| Syd Johnson | M | - | 23 Jahre | |
| Stephen Eck | M | 69 | 4 Jahre | |
| Rachael Easton | M | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark Robert Baker | M | 69 | 14 Jahre | |
| Chuck Wilson | M | 59 | 6 Jahre | |
| Henry McKinnell | M | 81 | 8 Jahre | |
| Jeffrey Kindler | M | 68 | 8 Jahre | |
| Dennis Ausiello | M | 78 | 13 Jahre | |
| Patrick Fabbio | M | 56 | 5 Jahre | |
| Bruce Booth | M | 49 | 6 Jahre | |
| Christian Hogg | M | 58 | 16 Jahre | |
| Nicole S. Williams | F | 79 | 12 Jahre | |
| Paulo Costa | M | 73 | 13 Jahre | |
| Ludwig Hantson | M | 61 | 1 Jahre | |
| Iwaaki Taniguchi | M | - | - | |
| George A. Lorch | M | 82 | 15 Jahre | |
| Shiro Kuniya | M | 67 | - | |
| Peter J. Crowley | M | 65 | 10 Jahre | |
| Christiana Stamoulis | F | 53 | 4 Jahre | |
| Angelo William Lovallo | M | 59 | 7 Jahre | |
| Antonio Gualberto | M | 59 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 13 Jahre |
| Reinhard Ambros | M | 67 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 Jahre |
| Jonathan Emms | M | - | 20 Jahre | |
| Stephen Buckley | M | 74 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | - |
| Frank Morich | M | 69 | 4 Jahre | |
| Paul Fitzhenry | M | 64 | 4 Jahre | |
| Fumio Sudo | M | 83 | 6 Jahre | |
| Christopher Huang | M | 72 | 11 Jahre | |
| Christopher S. James | M | - | 1 Jahre | |
| Liam Ratcliffe | M | 60 | 4 Jahre | |
| Campbell Murray | M | 48 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 Jahre |
| Daniel Curran | M | 57 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 13 Jahre |
| Susan Stewart | F | 64 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 6 Jahre |
| Jacob M. Plotsker | M | 56 | 16 Jahre | |
| Robert Perez | M | 59 | 1 Jahre | |
| Ann MacDougall | F | 70 | 1 Jahre | |
| Olivier Brandicourt | M | 68 | 13 Jahre | |
| Peter Corr | M | 76 | 6 Jahre | |
| Deborah Dunsire | M | 61 | 3 Jahre | |
| Francois Nader | M | 67 | 1 Jahre | |
| Michael R. Jirousek | M | 65 | 5 Jahre | |
| Bradley Campbell | M | 48 | 4 Jahre | |
| Cheryl Cohen | F | 58 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 Jahre |
| Robert N. Burt | M | 86 | 11 Jahre | |
| Gail Fosler | F | 76 | 1 Jahre | |
| Albert P. L. Stroucken | M | 76 | 1 Jahre | |
| William Herbert Gray | M | 82 | 13 Jahre | |
| George Milne | M | 80 | 32 Jahre | |
| Matthew Fust | M | 59 | 6 Jahre | |
| Tadataka Yamada | M | 78 | 4 Jahre | |
| David Scheinberg | M | 68 | 25 Jahre | |
| Michael Kishbauch | M | 75 | 6 Jahre | |
| Ken Galbraith | M | 61 | 14 Jahre | |
| Yorihiko Kojima | M | 82 | - | |
| Michael William Davis Howell | M | 76 | 11 Jahre | |
| Hiroshi Shinha | M | - | 38 Jahre | |
| Matthew Osborne | M | - | 1 Jahre | |
| Blake E. Devitt | M | 77 | 1 Jahre | |
| Jeffrey D. Summer | M | 64 | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 83 | 83,84% |
| Japan | 12 | 12,12% |
| Hong Kong | 6 | 6,06% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Karen Ferrante
- Persönliches Netzwerk
